Items where Author is "Tabarsi, P."

Article

(2022) Antibiotic use during the first 6 months of COVID-19 pandemic in Iran: A large-scale multi-centre study. J Clin Pharm Ther. ISSN 0269-4727

(2022) Prevalence of Human T-Lymphotropic Virus Type 1 in Brain-Dead Donors. ARCHIVES OF CLINICAL INFECTIOUS DISEASES. ISSN 2345-2641 2008-1081 J9 - ARCH CLIN INFECT DIS

(2021) Management of ST-segment-elevation myocardial infarction during the coronavirus disease 2019 (COVID-19) outbreak: Iranian"247" National Committee's position paper on primary percutaneous coronary intervention. Catheterization and Cardiovascular Interventions. E346-E351. ISSN 1522-1946

(2021) SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study. Lancet Infect Dis. pp. 473-481. ISSN 1473-3099 (Print) 1473-3099

(2020) COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine Practice and Policy Interest Group Position Paper. Basic and Clinical Neuroscience. pp. 133-149. ISSN 2008-126X

(2020) Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial. International Immunopharmacology. ISSN 1567-5769

(2019) Naturally occurring NS5A and NS5B resistant associated substitutions in HCV and HCV/HIV patients in iranian population. Clin Res Hepatol Gastroenterol. ISSN 2210-741X (Electronic) 2210-7401 (Linking)